DiaSorin Value Stock - Dividend - Research Selection
Market price: 161,80 EUR
DiaSorin S.R.L. Fundamental data and company key figures of the share
|Annual reports in EUR|
|Net operating cash flow||232.700.000|
|Free cash flow||202.700.000|
|Liabilities & Shareholders equity||916.700.000|
|Diluted shares outstanding||55.955.400|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||10.980.696.064,00 USD|
|Raw Data Source||IFRS in Millionen EUR|
Description of the company
DiaSorin S.p.A. engages in the development, production, and commercialization of diagnostic tests that are designed for hospital and private testing laboratories for use in various clinical areas in the market of immunodiagnostics and molecular diagnostics. The company offers immunodiagnostics products in the areas of infectious diseases; bone and mineral metabolism; endocrinology, including diabetes, thyroid function, fertility, growth, adrenal function, and gastroenterology; hypertension; oncology; stool diagnostics; autoimmunity; and cardiac and brain damages. Its immunodiagnostics systems include LIAISON XL, an automated chemiluminescence analyzer; LIAISON analyzer; EVOlyzer 2-150/8 with disposable tips; and ETI Max 3000, an automated microtiter plate analyzer. The company also offers molecular diagnostic products for oncology, hematology, and infectious diseases; systems, including BULLET Pro and LIAISON Ixt to extract the nucleic acid from various biological samples; and LIAISON Iam to diagnose and various infectious diseases and onco-hematology parameters. It sells its products directly, as well as through an international network of independent distributors in Europe, Africa, Central America, South America, the Asia Pacific, and North America. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy.